decisionhealth Newsletters, Part B News - 2000 Issue 11 (November)
Coverage decision scheduled for controversial imaging technique
Subscribe or sign in to view the full article.
Article Overview
This article covers a Medicare coverage review involving positron emission tomography (PET), the advisory committee discussion around how diagnostic imaging evidence should be assessed, and the possibility of several different types of coverage outcomes. It is relevant to coding, reimbursement, and health policy professionals who follow imaging technology, Medicare coverage policy, and specialty advocacy efforts related to oncology, cardiology, and dementia imaging.
Why This Topic Matters
Coverage decisions can affect whether a diagnostic imaging service is broadly available under Medicare and how providers, payers, and manufacturers plan for adoption of new technology. The article also highlights the broader policy process used to judge diagnostic tests, which can shape future coverage reviews beyond PET.
What You Will Learn
- How a Medicare coverage review for PET imaging is being discussed
- What role the advisory committee and agency review process play in coverage decisions
- Why diagnostic test evaluation methods are part of the policy debate
- Which clinical areas are being considered in the coverage discussion
Who Should Read This
- Medical coders
- Billing and reimbursement professionals
- Health policy analysts
- Radiology and imaging stakeholders
- Oncology and cardiology practice managers
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com